Profile data is unavailable for this security.
About the company
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test methods to characterize complex biologics, including cell therapy-based products, protein therapeutics, vaccines and advanced therapies. Its Clinical Biomanufacturing includes cGMP Mammalian Cell Culture, and cGMP Microbial Fermentation. Its San Antonio facility is focused on the commercial-scale manufacturing of biodefense-focused molecules and biologics therapeutics. Its biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies.
- Revenue in USD (TTM)9.74m
- Net income in USD-32.20m
- Incorporated2008
- Employees82.00
- LocationScorpius Holdings Inc627 DAVIS DRIVE, SUITE 300MORRISVILLE 27560United StatesUSA
- Phone+1 (919) 240-7133
- Fax+1 (302) 636-5454
- Websitehttps://www.nighthawkbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aditxt Inc | 506.45k | -41.45m | 2.73m | 47.00 | -- | 0.2297 | -- | 5.39 | -109.80 | -109.80 | 0.7488 | 5.96 | 0.0284 | 0.9296 | 1.34 | 10,775.53 | -231.82 | -192.78 | -658.00 | -321.59 | -27.22 | -- | -8,149.75 | -7,208.65 | 0.0562 | -3.42 | 0.3915 | -- | -30.90 | -- | -18.11 | -- | -- | -- |
| Virax Biolabs Group Ltd | 0.00 | -1.71m | 2.74m | 5.00 | -- | -- | -- | -- | -1.50 | -1.50 | 0.00 | -0.8568 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 0.0223 | -112.29 | -- | -- | -100.00 | -- | -162.50 | -- | -- | -- |
| Exicure Inc | 500.00k | -13.34m | 2.77m | 6.00 | -- | 1.25 | -- | 5.54 | -1.56 | -1.56 | 0.0582 | 0.2551 | 0.0289 | -- | -- | 83,333.34 | -76.97 | -41.52 | -91.14 | -55.78 | -- | -- | -2,667.20 | -290.95 | -- | -- | 0.00 | -- | -100.00 | -- | -555.07 | -- | -- | -- |
| Tharimmune Inc | 0.00 | -8.89m | 2.77m | 2.00 | -- | 0.3936 | -- | -- | -111.65 | -111.65 | 0.00 | 8.97 | 0.00 | -- | -- | 0.00 | -130.60 | -- | -173.40 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.98 | -- | -- | -- |
| Livewire Ergogenics Inc | 67.98k | -1.09m | 2.79m | 1.00 | -- | -- | -- | 41.04 | -0.0061 | -0.0061 | 0.0003 | -0.0022 | 0.1979 | 1.74 | 2.86 | 67,980.00 | -317.45 | -- | -- | -- | -113.70 | -- | -1,604.38 | -- | 0.1248 | -2.13 | -- | -- | 68.58 | -- | -3.64 | -- | -- | -- |
| Kiromic Biopharma Inc | 0.00 | -24.99m | 2.82m | 31.00 | -- | -- | -- | -- | -29.21 | -29.21 | 0.00 | -3.81 | 0.00 | -- | -- | 0.00 | -171.18 | -161.49 | -- | -213.01 | -- | -- | -- | -- | -- | -15.69 | 1.87 | -- | -- | -- | -35.90 | -- | 177.42 | -- |
| Axim Biotechnologies Inc | 85.35k | -5.59m | 2.89m | 6.00 | -- | -- | -- | 33.81 | -0.0249 | -0.0249 | 0.0003 | -0.0268 | 0.0214 | -- | -- | 14,225.00 | -140.13 | -154.34 | -- | -390.73 | -- | -- | -6,548.75 | -36,362.71 | -- | -1.16 | -- | -- | 345.05 | -27.38 | -29.10 | -- | -- | -- |
| Alzamend Neuro Inc | 0.00 | -12.40m | 2.91m | 4.00 | -- | -- | -- | -- | -1.87 | -1.87 | 0.00 | -0.572 | 0.00 | -- | -- | 0.00 | -267.15 | -- | -880.90 | -- | -- | -- | -- | -- | -- | -1,352.90 | -- | -- | -- | -- | -20.35 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 2.91m | 40.00 | -- | -- | -- | 1.05 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| Sonnet Biotherapeutics Holdings Inc | 92.74k | -8.43m | 2.92m | 12.00 | -- | 0.9553 | -- | 31.46 | -5.28 | -5.28 | 0.0315 | 0.9813 | 0.0097 | -- | 0.2248 | 7,728.33 | -87.68 | -- | -194.11 | -- | -- | -- | -9,086.22 | -- | -- | -138.21 | 0.00 | -- | -57.76 | -- | 36.64 | -- | -- | -- |
| Scorpius Holdings Inc | 9.74m | -32.20m | 2.93m | 82.00 | -- | 0.0382 | -- | 0.3006 | -1.22 | -1.40 | 0.3663 | 0.7937 | 0.1372 | -- | 26.56 | 118,815.70 | -47.81 | -39.37 | -58.20 | -43.18 | 68.56 | -- | -348.43 | -1,068.21 | 0.2641 | -198.18 | 0.3179 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
| Entero Therapeutics Inc | 0.00 | -6.44m | 3.04m | 15.00 | -- | 0.1539 | -- | -- | -51.90 | -51.90 | 0.00 | 38.45 | 0.00 | -- | -- | 0.00 | -12.74 | -295.92 | -14.01 | -1,599.51 | -- | -- | -- | -- | -- | -265.69 | 0.0802 | -- | -- | -- | -7.55 | -- | -- | -- |
| Revelation Biosciences Inc | 0.00 | -8.96m | 3.12m | 9.00 | -- | 0.3292 | -- | -- | -32.09 | -32.09 | 0.00 | 5.80 | 0.00 | -- | -- | 0.00 | -54.61 | -- | -91.95 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 98.89 | -- | -- | -- |
| DSwiss Inc | 1.68m | 144.71k | 3.12m | 11.00 | 21.57 | 13.30 | 15.97 | 1.86 | 0.0007 | 0.0007 | 0.0081 | 0.0011 | 4.43 | 189.17 | 35.95 | 152,321.80 | 38.27 | -8.69 | 79.40 | -45.47 | 32.65 | 25.55 | 8.64 | -2.47 | 2.04 | 66.93 | 0.1198 | -- | -20.50 | 46.20 | -688.36 | -- | -66.17 | -- |
| Zyversa Therapeutics Inc | 0.00 | -105.53m | 3.14m | 7.00 | -- | 0.2797 | -- | -- | -1,791.54 | -1,791.54 | 0.00 | 13.44 | 0.00 | -- | -- | 0.00 | -142.87 | -- | -164.77 | -- | -- | -- | -- | -- | -- | -17,576.86 | 0.00 | -- | -- | -- | -340.15 | -- | -- | -- |
Data as of Jun 28 2024. Currency figures normalised to Scorpius Holdings Inc's reporting currency: US Dollar USD
1.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 May 2024 | 363.72k | 0.38% |
| Warberg Asset Management LLCas of 31 Mar 2024 | 283.04k | 0.29% |
| Geode Capital Management LLCas of 30 Apr 2024 | 187.46k | 0.19% |
| UBS Securities LLCas of 31 Mar 2024 | 163.59k | 0.17% |
| Bridgeway Capital Management LLCas of 31 Mar 2024 | 100.00k | 0.10% |
| BG Fund Management Luxembourg SAas of 31 Dec 2023 | 71.63k | 0.07% |
| XTX Markets LLCas of 31 Mar 2024 | 26.62k | 0.03% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 24.54k | 0.03% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 20.27k | 0.02% |
| Edmond de Rothschild (Suisse) SA (Investment Management)as of 31 Mar 2024 | 14.29k | 0.02% |
More ▼
Data from 31 Mar 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
